Post-Adjuvant Therapy for HER2+ Breast Cancer

Treatment de-escalation and escalation strategies in HER2-positive breast cancerПодробнее

Updates in Systemic Therapy for Breast Cancer 2/8/23Подробнее

Post neoadjuvant management in BRCA mutant breast cancer patientsПодробнее

Differential long-term benefit of adjuvant tamoxifen in ER+/HER2- premenopausal + postmenopausal BCПодробнее

Dr Vikas Talreja | Neo Adjuvant systemic therapy in patients with early HER2 positive breast cancerПодробнее

The predictive value of treatment response after neoadjuvant therapyПодробнее

A post hoc analysis of adjuvant radiation therapy in the KEYNOTE-522 studyПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Adjuvant treatment guidelines in post-menopausal women with breast cancerПодробнее

ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancerПодробнее

NBE- NEO ADJUVANT THERAPY BREAST CANCER- SURGEONS PERSPECTIVE- RECENT ADVANCES- DR. SOMASHEKHAR SPПодробнее

breast cancer 2022Подробнее

Breast Cancer Treatment Part 2Подробнее

2022 West Oncology Conference | Breast Cancers | Early-StageПодробнее

BBCC 2 - Hot topics in management of breast cancerПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

BBCC 2022 - Neoadjuvant therapy of breast cancerПодробнее

ASCO 2022: Metastatic Breast Cancer Drug Therapy RecapПодробнее

Breast Cancer Update | 2022 Metro Denver Oncology Nursing Society ConferenceПодробнее